Pulaski Law Firm TV Spot, 'Rheumatoid Arthritis'
Get Free Access to the Data Below for 10 Ads!
- National Airings
- 🔒
- First Airing
- 🔒
- Last Airing
- 🔒
- Creatives
- 🔒
- Recently Aired On
- 🔒
- Est. Spend
- 🔒
- TV Impressions
- 🔒
- National Impressions
- 🔒
- Local Impressions
- 🔒
There's a Better Way to Measure TV & Streaming Ad ROI
- Real-Time Ad Measurement Across Linear and CTV
- TV Ad Attribution & Benchmarking
- Marketing Stack Integrations and Multi-Touch Attribution
- Real-Time Video Ad Creative Assessment
A spokesperson for the Pulaski Law Firm warns against the Rheumatoid Arthritis drug Xeljanz, claiming that a recent clinical trial found an increased risk of blood clots and death in patients taking a twice daily dose. The Pulaski Law Firm suggests calling immediately to see if you qualify for compensation.
- Published
- April 13, 2019
- Advertiser
- Pulaski Law Firm
- Songs
- None have been identified for this spot
- Phone
- 800-645-4085
- Mood
- Informational
- Actors - Add
- None have been identified for this spot.
-
Have questions about this ad or our catalog? Check out our FAQ Page.
- Screenshots
-
-
Screenshot
×